UK experience of treosulfan-based conditioning regimens in children with primary immunodeficiency

被引：0
|
作者：
Slatter, M. [1 ]
Rao, K. [2 ]
Amrolia, P. [2 ]
Flood, T.
Abinun, M. [1 ]
Cant, A. [1 ]
Hambleton, S. [3 ]
Goulden, N. [2 ]
Davies, G. [2 ]
Qasim, W. [2 ]
Gasper, H. B. [2 ]
Gennery, A. [1 ]
Veys, P. [2 ]
机构：
[1] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
[2] Great Ormond St Hosp NHS Trust, London, England
[3] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S73 / S74
页数：2
相关论文
共 50 条
  • [41] Treosulfan-based conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with non-malignant diseases
    Jin Kyung Suh
    Ho Joon Im
    Sung Han Kang
    Hyery Kim
    Eun Seok Choi
    Kyung-Nam Koh
    Bone Marrow Transplantation, 2022, 57 : 681 - 684
  • [42] Treosulfan-based conditioning for Stem Cell Transplantation in Non-malignant Diseases - The Experience of four German Centers
    Sirin, M.
    Hoenig, M.
    Mueller, I.
    Sykora, K. -W.
    Beier, R.
    Furlan, I.
    Schulz, A. S.
    Albert, M. H.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S11 - S12
  • [43] IMPACT OF PRETRANSPLANT MRD IN PATIENTS ALLOGRAFTED FOR AML AFTER TREOSULFAN-BASED CONDITIONING
    Pyka, Jacob
    Leimkuehler, Nils
    Schneider, Artur
    Kaivers, Jennifer
    Trenschel, Rudolf
    Mohring, Annemarie
    Reinhardt, Christian
    Schroeder, Thomas
    Rautenberg, Christina
    BONE MARROW TRANSPLANTATION, 2024, 59 : 261 - 262
  • [44] Treosulfan-based Reduced-intensity Allogeneic Hematopoietic Cell Transplantation in Adults With Primary Immunodeficiency: A Case Series
    Dalla Via, Vera
    Stelmes, Anne
    Recher, Mike
    Arranto, Christian
    Junker, Till
    Matteazzi, Francesca
    Heim, Dominik
    Passweg, Jakob R.
    Medinger, Michael
    van den Berg, Jana
    ANTICANCER RESEARCH, 2022, 42 (09) : 4505 - 4509
  • [45] Treosulfan-based reduced-intensity allogeneic hematopoietic cell transplantation in adults with primary immunodeficiency: a case series
    Dalla Via, V.
    Stelmes, A.
    Recher, M.
    Arranto, C.
    Junker, T.
    Matteazzi, F.
    Heim, D.
    Passweg, J.
    Medinger, M.
    van den Berg, J.
    SWISS MEDICAL WEEKLY, 2022, 152 : 19S - 19S
  • [46] Treosulfan-based conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with non-malignant diseases
    Suh, Jin Kyung
    Im, Ho Joon
    Kang, Sung Han
    Kim, Hyery
    Choi, Eun Seok
    Koh, Kyung-Nam
    BONE MARROW TRANSPLANTATION, 2022, 57 (04) : 681 - 684
  • [47] The impact of Treosulfan-based conditioning for inborn errors of immunity: Is dose monitoring crucial?
    Ersoy, Gizem Zengin
    Cipe, Funda
    Fisgin, Tunc
    Aksoy, Basak Adakli
    Oner, Ozlem Basoglu
    Hashemi, Nazli
    Aydogdu, Selime
    Erdem, Melek
    Dikme, Guercan
    Murat, Koza
    Bozkurt, Ceyhun
    CLINICAL TRANSPLANTATION, 2023, 37 (09)
  • [48] Treosulfan-based conditioning regimen for allogeneic transplantation in children congenital non-malignant disorders - retrospective study
    Wachowiak, J.
    Grund, G.
    Sykora, K-W.
    Wynn, R. F.
    Kowalczyk, J.
    Drabko, K.
    Smiers, F.
    Bredius, R. G. M.
    Veys, P.
    Chybicka, A.
    Kalwak, K.
    Steward, C.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S295 - S295
  • [49] Treosulfan-based conditioning in pediatric hematopoietic stem cell transplantation: a prospective study on treosulfan exposure and clinical outcome
    Stoep, E. V.
    ten Brink, M.
    Bertaina, A.
    Smiers, F.
    Bredius, R.
    Moes, D. J.
    Locatelli, F.
    Guchelaar, H-J
    Zwaveling, J.
    Lankester, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S113 - S114
  • [50] THE IMPACT OF TREOSULFAN -BASED CONDITIONING FOR PRIMARY IMMUNE DEFICIENCIES: SINGLE CENTER EXPERIENCE
    Ersoy, Gizem Zengin
    Cipe, Funda
    Alsoy, Basak Adakli
    Hashemi, Nazli
    Oner, Ozlem Basoglu
    Aydogdu, Selime
    Dikme, Gurcan
    Erdem, Melek
    Bozkurt, Ceyhun
    Fisgin, Tunc
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 269 - 270
12345